NCT06671275View on ClinicalTrials.gov

A Clinical Study to Evaluate CUD005 Injection in Patients with Liver Cirrhosis

PHASE1Enrolling by invitationINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

June 21, 2024

Primary Completion Date

October 31, 2025

Study Completion Date

July 31, 2026

Conditions
Cirrhosis Liver
Interventions
BIOLOGICAL

Cell therapy

Subjects were placed sequentially into three different dose groups, 5.0×107 cells/time (low-dose group), 1.5×108 cells/time (medium-dose group), and 5.0×108 cells/time (high-dose group) for dose escalation

Trial Locations (1)

230000

Lianxin Liu, Hefei

All Listed Sponsors
lead

Anhui Provincial Hospital

OTHER_GOV